Antibodies directed against Staphylococcus aureus leukotoxins
US11059884B2 · kind B2 · utility
4Cited by
5References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 8, 2019 |
| Grant date | Jul 13, 2021 |
| Priority date | — |
| Expiry date | Oct 8, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to leukotoxin-binding antibodies and antigen-binding fragments thereof. The antibodies and fragments can be used, for example, to detect leukotoxin and/or in methods of treating and preventing Staphylococcus aureus infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.